ArticleInfection and drug resistance2022

A Pilot Study of 0.4% Povidone-Iodine Nasal Spray to Eradicate SARS-CoV-2 in the Nasopharynx.

Rujipas Sirijatuphat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.